Wolverine Trading, LLC Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$212.22 - $292.96 $679,104 - $937,471	-3,200 Reduced 20.78%	12,200 $2.59 Million
Q2 2024 Aug 14, 2024	SELL	$193.33 - $291.99 $1.97 Million - $2.98 Million	-10,200 Reduced 39.84%	15,400 $4.31 Million
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $3.34 Million - $5.52 Million	19,500 Added 319.67%	25,600 $6.84 Million
Q4 2023 Feb 14, 2024	SELL	$120.4 - $237.13 $168,560 - $331,982	-1,400 Reduced 18.67%	6,100 $1.41 Million
Q3 2023 Nov 15, 2023	SELL	$146.04 - $225.78 $847,032 - $1.31 Million	-5,800 Reduced 43.61%	7,500 $1.1 Million
Q2 2023 Aug 23, 2023	BUY	$203.88 - $312.0 $856,296 - $1.31 Million	4,200 Added 46.15%	13,300 $3.07 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $2.1 Million - $2.79 Million	9,100 New	9,100 $2.14 Million
Q3 2022 Nov 14, 2022	SELL	$60.57 - $79.51 $109,026 - $143,118	-1,800 Reduced 16.22%	9,300 $585,000
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $156,708 - $270,540	2,700 Added 32.14%	11,100 $799,000
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $14,468 - $19,018	-200 Reduced 2.33%	8,400 $713,000
Q3 2021 Nov 12, 2021	BUY	$78.35 - $105.02 $383,915 - $514,598	4,900 Added 132.43%	8,600 $688,000
Q1 2021 May 14, 2021	SELL	$108.54 - $125.2 $43,416 - $50,080	-400 Reduced 9.76%	3,700 $431,000
Q3 2020 Nov 13, 2020	BUY	$99.78 - $124.21 $409,098 - $509,261	4,100 New	4,100 $489,000

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.28B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.